A computational study suggests that replacing PEG with PMOZ may increase exposure of hydrophobic targeting moiety

被引:17
作者
Magarkar, Aniket [1 ,2 ]
Rog, Tomasz [3 ]
Bunker, Alex [1 ]
机构
[1] Univ Helsinki, Fac Pharm, Drug Res Program, Helsinki, Finland
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic
[3] Univ Helsinki, Dept Phys, Helsinki, Finland
基金
芬兰科学院;
关键词
Polyoxazolines; Targeted delivery; PEGylation; Liposome; Nanomedicine; Molecular dynamics; MOLECULAR-DYNAMICS SIMULATION; RGD-BASED STRATEGIES; DRUG-DELIVERY; POLY(ETHYLENE GLYCOL); CANCER-THERAPY; PEGYLATED LIPOSOMES; POTENTIAL FUNCTIONS; REPEATED INJECTIONS; NANOMEDICINE; NANOPARTICLES;
D O I
10.1016/j.ejps.2017.03.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a previous study we showed that the cause of failure of a new, proposed, targeting ligand, the AETP moiety, when attached to a PEGylated liposome, was occlusion by the polyethylene glycol) (PEG) layer due to its hydrophobic nature, given that PEG is not entirely hydrophilic. At the time we proposed that possible replacement with a more hydrophilic protective polymer could alleviate this problem. In this study we have used computational molecular dynamics modelling, using a model with all atom resolution, to suggest that a specific alternative protective polymer, poly(2-methyloxazoline) (PMOZ), would perform exactly this function. Our results show that when PEG is replaced by PMOZ the relative exposure to the solvent of AETP is increased to a level even greater than that we found in previous simulations for the RGD peptide, a targeting moiety that has previously been used successfully in PEGylated liposome based therapies. While the AETP moiety itself is no longer under consideration, the results of this computational study have broader significance: the use of PMOZ as an alternative polymer coating to PEG could be efficacious in the context of more hydrophobic targeting ligands. In addition to PMOZ we studied another polyoxazoline, poly(2-ethyloxazoline) (PEOZ), that has also been mooted as a possible alternate protective polymer. It was also found that the RDG peptide occlusion was significantly greater for the case of both oxazolines as opposed to PEG and that, unlike PEG, neither oxazoline entered the membrane. As far as we are aware this is the first time that polyoxazolines have been studied using molecular dynamics simulation with all atom resolution. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 77 条
  • [1] [Anonymous], 2016, AMBER
  • [2] Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
    Armstrong, Jonathan K.
    Hempel, Georg
    Koling, Susanne
    Chan, Linda S.
    Fisher, Timothy
    Meiselman, Herbert J.
    Garratty, George
    [J]. CANCER, 2007, 110 (01) : 103 - 111
  • [3] Doxil® - The first FDA-approved nano-drug: Lessons learned
    Barenholz, Yechezkel
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) : 117 - 134
  • [4] Cancer active targeting by nanoparticles: a comprehensive review of literature
    Bazak, Remon
    Houri, Mohamad
    El Achy, Samar
    Kamel, Serag
    Refaat, Tamer
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 769 - 784
  • [5] The Effect of Hofmeister Salts on the LCST Transition of Poly(2-oxazoline)s with Varying Hydrophilicity
    Bloksma, Meta M.
    Bakker, Daniel J.
    Weber, Christine
    Hoogenboom, Richard
    Schubert, Ulrich S.
    [J]. MACROMOLECULAR RAPID COMMUNICATIONS, 2010, 31 (08) : 724 - 728
  • [6] Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylation
    Bunker, Alex
    Magarkar, Aniket
    Viitala, Tapani
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2016, 1858 (10): : 2334 - 2352
  • [7] Targeted Drugs and Nanomedicine: Present and Future
    Debbage, Paul
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (02) : 153 - 172
  • [8] Stearylated cycloarginine nanosystems for intracellular delivery - simulations, formulation and proof of concept
    Dhawan, V.
    Magarkar, A.
    Joshi, G.
    Makhija, D.
    Jain, A.
    Shah, J.
    Reddy, B. V. V.
    Krishnapriya, M.
    Rog, T.
    Bunker, A.
    Jagtap, A.
    Nagarsenker, M.
    [J]. RSC ADVANCES, 2016, 6 (114) : 113538 - 113550
  • [9] Solubility Profiles of Poly(ethylene glycol)/Solvent Systems. II. Comparison of Thermodynamic Parameters from Viscosity Measurements
    Dinc, Cemile Ozdemir
    Kibarer, Guenay
    Guner, Ali
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 2010, 117 (02) : 1100 - 1119
  • [10] The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
    Doane, Tennyson L.
    Burda, Clemens
    [J]. CHEMICAL SOCIETY REVIEWS, 2012, 41 (07) : 2885 - 2911